Description
Inclusion Criteria:
- * Documented endoscopic diagnosis of ulcerative colitis
- * Currently being treated with a stable dose of 5-ASAs, steroids, or any other medication approved for ulcerative colitis
- * If on 5-ASA, no dose changes within 2 weeks before the Day 0 visit
- * If on steroids, prednisone dose not more than 20 mg daily and entocort not more than 9 mg daily, with no dose changes within 2 weeks before the Day 0 visit
- * All other medications require a stable dose for at least 8 weeks prior to enrollment.
- * No dose changes to any IBD medication anticipated for the duration of the study
- * Body Mass Index (BMI) values 18.5-40 kg/m2
- * Not on total parenteral nutrition (TPN) or receiving tube feeds.
- * Ability to understand the study procedures, benefits and risks, and sign a written informed consent document.
- * Able to fill out questionnaires regarding dietary intakes, bowel symptoms, and study experience
Exclusion Criteria:
- * Taking Non-steroidal anti-inflammatory drugs (NSAIDs)
- * Following a medically-prescribed diet, on Total parenteral nutrition (TPN), or tube feeds
- * Newly diagnosed (within past month), or uncontrolled diabetes or cardiovascular disease
- * Antibiotics in the previous 2 weeks
- * Consumption of more than 5 ½ cups of servings/day of fruits and vegetables as assessed by the National Cancer Institute (NCI) Diet History Questionaire III online Food Questionnaire.
- * A known allergy or sensitivity to cruciferous vegetables like arugula, bok choy, broccoli, cabbage, cauliflower, or collard greens
Ages Eligible for Study:
18 Years to N/A (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
No